Lexeo Therapeutics (LXEO) COO Jose Otero Sells 1,304 Shares

What Happened

• Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics (LXEO), sold 1,304 shares in an open-market transaction on 2026-08-18. The weighted average sale price was $4.96 per share, for total proceeds of approximately $6,464. This was a sale (routine/liquidity event), not a purchase.

Key Details

• Transaction date: 2026-08-18 (reported on Form 4 filed 2026-08-19)
• Prices: weighted average $4.96; individual trades ranged $4.94–$5.01 (multiple trades) — reporting person can provide per-trade breakdown on request (see footnote F2)
• Total shares sold: 1,304; total proceeds: ~$6,464
• Purpose: Sale to cover tax obligations related to the release of restricted stock units (RSUs) (footnote F1)
• Holdings note: Filing indicates holdings include 97,026 Restricted Stock Units (footnote F3). The exact number of shares owned following this transaction was not specified in the provided data.
• Timeliness: Form 4 was filed the next day (2026-08-19) for the 2026-08-18 transaction, which appears timely under Form 4 reporting rules.

Context

• This sale was made to satisfy tax withholding on RSU vesting — a common, routine insider transaction that is not necessarily a signal about company prospects. No options were exercised and this was not a gift or a 10% owner transaction.